Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) — a life-threatening fungal infection primarily affecting children and ... Pneumocystis pneumonia is a potentially life-endangering disease caused by the fungal pathogen Pneumocystis jiroveci. It is predominantly observed in immunocompromised individuals.
This microorganism ... JSTOR Daily: β-Glucans Are Masked but Contribute to Pulmonary Inflammation During Pneumocystis Pneumonia Patients with dermatomyositis who were positive for a myositis-specific antibody had a much higher incidence of and mortality associated with Pneumocystis jirovecii infection than patients with other ... Currently, the detection of the fungus in patients, who may be asymptomatic carriers until they develop pneumonia, uses the PCR technique, which takes several hours and requires adequate facilities ... EurekAlert!: Breakthrough CRISPR-based test offers faster, more accurate diagnosis for fungal pneumonia β-glucans, which can activate innate immune responses, are a major component in the cell wall of the cyst form of Pneumocystis.
pneumocystis jirovecii pneumonia, In the current study, we examined whether β-1,3-glucans are masked by ... FierceBiotech: Myconostica Announces Presentation Of Positive Multi-Centre Multinational Clinical Evaluation Data For MycassayTM Pneumocystis
